Literature DB >> 7114074

Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination.

J D Sobel, N Hashman, G Reinherz, D Merzbach.   

Abstract

During the period of January to July 1980, a marked increase in the number of Pseudomonas cepacia isolates was observed in a microbiologic surveillance program. Although P. cepacia was isolated from wound specimens and vaginal cultures, the majority of isolates were of urinary origin from catheterized patients. Retrospective chart analysis of the patients failed to verify a causal pathogenic role for P. cepacia. However, fulminant sepsis subsequently developed in two hospitalized immunocompromised patients, with both blood and urine cultures positive for P. cepacia. Investigation revealed the presence of this organism in chlorhexidine (0.2 percent) mouthwash as well as other chlorhexidine antiseptic solutions used for routine urologic and obstetric procedures. The source of the P. cepacia was identified as the rubber tubing in the pharmacy through which deionized water passed during the dilution of concentrated (5 percent) chlorhexidine gluconate. In vitro tests demonstrated that P. cepacia was resistant to 0.2 percent chlorhexidine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7114074     DOI: 10.1016/0002-9343(82)90176-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  26 in total

1.  Two cases of Burkholderia cepacia endophthalmitis.

Authors:  I Eser; T Altan; J E Stahl; M D Aydin; N Inan; Z Kapran; O F Yilmaz
Journal:  Br J Ophthalmol       Date:  2006-09       Impact factor: 4.638

Review 2.  Outbreaks associated with contaminated antiseptics and disinfectants.

Authors:  David J Weber; William A Rutala; Emily E Sickbert-Bennett
Journal:  Antimicrob Agents Chemother       Date:  2007-10-01       Impact factor: 5.191

3.  Biocide susceptibility of the Burkholderia cepacia complex.

Authors:  Helen Rose; Adam Baldwin; Christopher G Dowson; Eshwar Mahenthiralingam
Journal:  J Antimicrob Chemother       Date:  2009-01-18       Impact factor: 5.790

4.  Emergence of Burkholderia cepacia in Honolulu: a case of nursing home-acquired B. cepacia sepsis.

Authors:  Charles Nc Hua; Jinichi Tokeshi
Journal:  Hawaii J Med Public Health       Date:  2013-09

5.  Plasmids of Pseudomonas cepacia strains of diverse origins.

Authors:  E Lennon; B T DeCicco
Journal:  Appl Environ Microbiol       Date:  1991-08       Impact factor: 4.792

Review 6.  HIV and decontamination procedures.

Authors:  E M Cooke
Journal:  BMJ       Date:  1989-07-08

Review 7.  The epidemiology of nosocomial epidemic Pseudomonas cepacia infections.

Authors:  W J Martone; O C Tablan; W R Jarvis
Journal:  Eur J Epidemiol       Date:  1987-09       Impact factor: 8.082

8.  Burkholderia cepacia endophthalmitis, in a penicillin allergic patient, following a ranibizumab injection.

Authors:  Norman Saffra; Emily Moriarty
Journal:  BMJ Case Rep       Date:  2014-02-13

9.  Virulence of different Pseudomonas species in a burned mouse model: tissue colonization by Pseudomonas cepacia.

Authors:  G B Stover; D R Drake; T C Montie
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

Review 10.  Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health?

Authors:  A Holmes; J Govan; R Goldstein
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.